Wilson John Robert 4
4 · Allovir, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Wilson John Robert
Director
Transactions
- Sale
Common Stock
2021-03-09$31.70/sh−30,506$966,921→ 5,480,008 total(indirect: See Footnote) - Sale
Common Stock
2021-03-09$31.70/sh−10,169$322,318→ 3,187,306 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$30.93/sh−28,402.75$878,449→ 5,451,605.25 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$30.93/sh−9,467.25$292,807→ 3,177,838.75 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$31.59/sh−8,418.75$265,974→ 3,169,420 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$32.31/sh−300$9,694→ 3,169,120 total(indirect: See Footnote) - Sale
Common Stock
2021-03-09$31.30/sh−52,440$1,641,157→ 5,510,514 total(indirect: See Footnote) - Sale
Common Stock
2021-03-11$31.63/sh−2,308$72,997→ 5,412,953 total(indirect: See Footnote) - Sale
Common Stock
2021-03-09$31.30/sh−17,480$547,052→ 3,197,475 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$31.59/sh−25,256.25$797,921→ 5,426,349 total(indirect: See Footnote) - Sale
Common Stock
2021-03-10$32.31/sh−900$29,081→ 5,425,449 total(indirect: See Footnote) - Sale
Common Stock
2021-03-11$30.87/sh−10,188$314,535→ 5,415,261 total(indirect: See Footnote) - Sale
Common Stock
2021-03-11$30.87/sh−3,397$104,876→ 3,165,723 total(indirect: See Footnote) - Sale
Common Stock
2021-03-11$31.63/sh−769$24,322→ 3,164,954 total(indirect: See Footnote)
Footnotes (10)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F6]Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.